Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) caused by nerve inflammation that affects over 2 million people globally. Bromodomain and extra-terminal domain (BET) proteins, containing BD1 and BD2 bromodomains, are among the proteins dysregulated in MS.